In this study we have demonstrated that both CD44 (the hyaluronan (HA) rece
ptor) and c-Src kinase are expressed in human ovarian tumor cells (SK-OV-3.
ipl cell line), and that these two proteins are physically associated as a
complex in vivo. Using a recombinant cytoplasmic domain of CD44 and an in v
itro binding assay, we have detected a specific interaction between CD44 an
d c-Src kinase, Furthermore, the binding of HA to SK-OV-3.ipl cells promote
s c-Src kinase recruitment to CD44 and stimulates c-Src kinase activity, wh
ich, in turn, increases tyrosine phosphorylation of the cytoskeletal protei
n, cortactin, Subsequently, tyrosine phosphorylation of cortactin attenuate
s its ability to cross-link filamentous actin in vitro. In addition, transf
ection of SK-OV-3.ipl cells with a dominant active form of c-Src (Y527F)cDN
A promotes CD44 and c-Src association with cortactin in membrane projection
s, and stimulates HA-dependent/CD44-specific ovarian tumor cell migration.
Finally, overexpression of a dominant-negative mutant of c-Src kinase (K295
R) in SK-OV-3.ipl cells impairs the tumor cell-specific phenotype, Taken to
gether, these findings strongly suggest that CD44 interaction with c-Src ki
nase plays a pivotal role in initiating cortactin-regulated cytoskeleton fu
nction and HA-dependent tumor cell migration, which may be required for hum
an ovarian cancer progression.